Avanafil 50mg/ml @ 30ml

Revo Peptide offers Avanafil 50mg/ml in a 30ml liquid formulation, manufactured to a verified purity of ≥98% for exclusive use in licensed laboratory and scientific research environments. This compound is supplied as a ready-dissolved liquid solution intended for in vitro investigational applications. For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.

Product Overview

Avanafil (CAS 841205-47-8) is a selective phosphodiesterase type 5 (PDE5) inhibitor that has attracted significant interest in pharmacological and biochemical research. Supplied by Revo Peptide at a concentration of 50mg per milliliter in a 30ml vial, this formulation provides researchers with a precisely measured, high-purity liquid compound suitable for a range of controlled in vitro studies. Its well-characterized mechanism of PDE5 inhibition makes it a valuable reference compound for investigators studying cyclic nucleotide signaling pathways, enzyme kinetics, and related biochemical processes.

Peptide Structure & Amino Acid Sequence

Avanafil is a small-molecule synthetic compound rather than a peptide, and therefore does not possess an amino acid sequence. Its molecular formula is C₂₃H₂₆ClFN₆O₂, with a molecular weight of approximately 483.95 g/mol. The compound features a pyrimidine core linked to a chloro-substituted benzyl amine and a fluorobenzyl piperazine moiety, structural elements that confer its high selectivity for PDE5 over other phosphodiesterase isoforms. This well-defined chemical architecture supports reproducible research outcomes and consistent batch-to-batch analytical profiles.

Chemical & Physical Characteristics

Each vial of Avanafil supplied by Revo Peptide presents as a clear liquid solution at the stated concentration of 50mg/ml. Key physical and chemical parameters include:

• CAS Number: 841205-47-8
• Molecular Formula: C₂₃H₂₆ClFN₆O₂
• Molecular Weight: ~483.95 g/mol
• Appearance: Clear liquid
• Physical State: Liquid formulation at supplied concentration
• Concentration: 50mg per milliliter
• Volume: 30ml per vial

These characteristics make the compound immediately suitable for aliquoting and integration into laboratory workflows without the need for additional dissolution steps.

Purity & Analytical Verification (HPLC & MS)

Revo Peptide subjects every production batch of Avanafil to rigorous analytical testing prior to release. Purity is confirmed at ≥98% using high-performance liquid chromatography (HPLC), and molecular identity is verified through mass spectrometry (MS). Certificates of Analysis (CoA) reflecting these results are available upon request for each lot number, supporting full traceability and data integrity in your research documentation.

Quality Control & Lyophilization Integrity

Unlike lyophilized peptides, Avanafil from Revo Peptide is supplied in liquid form, eliminating reconstitution variability. Quality control protocols encompass concentration verification, sterile filtration of the solution, and visual inspection for particulates or discoloration prior to dispatch. Each vial is sealed to prevent contamination and preserve compound integrity throughout transit and initial storage.

Safety, Handling & Laboratory Precautions

This compound is intended exclusively for trained laboratory personnel operating within appropriately equipped research facilities. Standard laboratory safety practices must be observed at all times, including the use of personal protective equipment (PPE) such as gloves, safety goggles, and lab coats. Avoid inhalation of vapors and direct skin or eye contact. Dispose of all materials in accordance with your institution’s chemical waste disposal regulations. This product is not approved for any form of human or animal administration.

Reconstitution, Packaging & Storage

Avanafil 50mg/ml is supplied as a pre-dissolved liquid solution and requires no reconstitution. Each vial should be stored at 2–8°C under refrigeration when in active use, and at −20°C for extended long-term storage. Protect from light and moisture. Avoid repeated freeze-thaw cycles to preserve compound stability and concentration accuracy. Vials are packaged in tamper-evident, research-grade containers appropriate for laboratory environments.

Intended Research Use & Market Positioning

Avanafil is positioned as a premium-grade reference compound for researchers investigating PDE5 inhibition mechanisms, cyclic GMP signaling cascades, vascular smooth muscle biology, and enzyme selectivity profiling. Revo Peptide supplies this compound strictly for in vitro and preclinical research applications. It is not positioned, labeled, or intended for therapeutic, diagnostic, or consumptive use of any kind. Researchers seeking a reliable, high-purity, competitively priced research compound will find Avanafil 50mg/ml at Revo Peptide to be a best-in-class option for their investigational needs.

Ordering, Availability & Fulfillment

Revo Peptide makes it straightforward to buy Avanafil online with confidence. Orders are processed promptly, and bulk purchasing options are available for laboratories requiring larger quantities. Discounts are automatically applied in the shopping cart for qualifying multi-vial orders, making Revo Peptide the best-price destination for research-grade Avanafil. Fast dispatch, secure packaging, and reliable fulfillment are standard with every order placed through our store.

Legal & Regulatory Disclaimer

For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications. Avanafil 50mg/ml supplied by Revo Peptide is intended solely for use by qualified researchers in controlled laboratory settings. Purchasers are solely responsible for ensuring compliance with all applicable local, national, and international laws and regulations governing the procurement, possession, and use of research compounds. Revo Peptide makes no therapeutic claims and assumes no liability for misuse of this product outside its intended research context.